Takeda Pharmaceutical (TAK) Operating Expenses (2025)
Takeda Pharmaceutical has reported Operating Expenses over the past 1 years, most recently at -$1.9 billion for Q4 2025.
- For Q4 2025, Operating Expenses changed N/A year-over-year to -$1.9 billion; the TTM value through Mar 2026 reached -$1.9 billion, changed N/A, while the annual FY2026 figure was -$11.7 billion, 2.93% up from the prior year.
- Operating Expenses was -$1.9 billion for Q4 2025 at Takeda Pharmaceutical.
- Across five years, Operating Expenses topped out at -$1.9 billion in Q4 2025 and bottomed at -$1.9 billion in Q4 2025.